NCT05021770 2021-08-26
Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma
Sun Yat-sen University
Phase 1/2 Unknown
Clinical Trials
3 trialsNCT02507479 2016-04-20
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT01148173 2010-06-22
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas
Charite University, Berlin, Germany
Phase 2 Unknown